Thyroid hormone receptors and type I iodothyronine 5′-deiodinase activity of human thyroid toxic adenomas and benign cold nodules

Summary

The majority of thyroid adenomas are of clonal origin. In a subset of toxic adenomas (TAs) and cold nodules (CNs) activating mutations in the thyrotropin (TSH) receptor or G_s-α gene may explain the altered functions in these benign tumours. The present study was undertaken to investigate the status of functional thyroid hormone receptors, major thyroid hormone signal mediators, in both the human TAs and CNs in comparison with a normal thyroid tissue from the same patient. Electrophoretic mobility shift assays using a DR4 (“direct repeats” 4), a thyroid hormone responsive element (TRE) of human type I iodothyronine 5′-deiodinase demonstrated the DNA-binding of thyroid hormone receptors (TRs) in thyroid tissue nuclear extracts. A significant increase (p < 0.05) in the functional binding properties of TRs to the DR4 thyroid hormone responsive element was found in TAs when compared to normal thyroid tissue. Contrary, a marked diminution in the TR-TRE complex formation was found in CNs in comparison with normal thyroid tissue. In addition, functional activity of the iodothyronine 5′-deiodinase (5′DI) was analyzed in benign tumours, thyroid TAs and CNs in comparison with that of normal thyroid tissue. A significantly increased (p < 0.01) activity of 5′DI was demonstrated in TAs, and in contrast, decreased values of the enzyme activity were found in CNs when compared to a normal tissue.

From the data it is suggested that both the status of TR-TRE complex formation and the activity of the 5′DI may be altered in benign tumours of human thyroid gland.

Key words:

Thyroid hormone receptor - Type I iodothyronine 5′-deiodinase - Electrophoretic mobility shift assay - Human thyroid - Toxic adenoma - Cold nodule

References

• 1 Andrews N C, Faller D V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.  Nucleic Acids Res. 1991;  19 2499
• 2 Beckett G J, Arthur J R. Hormone-nuclear receptor interactions in health and disease. The iodothyronine deiodinases and 5′-deiodination.  Baillieres Clin Endocrinol Metab. 1994;  8 285-304
• 3 Derwahl M. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas.  Exp Clin Endocrinol Diabetes. 104 ((Suppl. 4)) 1996;  32-40
• 4 Derwahl M, Hamacher C, Russo D, Broecker M, Manole D, Schatz H, Kopp P, Filetti S. Constitutive activation of the G_sα protein-adenylate cyclase pathway may not be sufficient to generate toxic adenomas.  J Clin Endocrinol Metab. 1996;  81 1898-1904
• 5 Evans R M. The steroid and thyroid hormone receptor superfamily.  Science. 1988;  240 889-895
• 6 Farid N R, Shi Y, Zou M. Molecular basis of thyroid cancer.  Endocr Rev. 1994;  15 202-231
• 7 Gärtner R, Veitenhansl M, Aktas J, Schopohl D. Role of fibroblast growth factor in the pathogenesis of nodular goiter.  Exp Clin Endocrinol Diabetes. 104 ((Suppl. 4)) 1996;  36-38
• 8 Glass C K. Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors.  J Endocrinol. 1996;  150 349-357
• 9 Hamacher C, Studer H, Zbaeren J, Schatz H, Derwahl M. Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors.  J Clin Endocrinol Metab. 1995;  80 1724-1732
• 10 Jakobs T C, Schmutzler C, Meissner-Weigl J, Köhrle J. The promoter of the human type I 5′-deiodinase gene: Mapping of the transcription start site and identification of a DR + 4 thyroid-hormone responsive element.  Eur J Biochem. 1997;  247 288-297
• 11 Köhrle J, Oertel M, Hoang-Vu C, Schnieders F, Brabant G. Type I 5′-deiodinase a marker for differentiated thyroid carcinoma?.  Exp Clin Endocrinol. 1993;  101 60-72
• 12 Köhrle J. Thyroid hormone deiodination in target tissues - a regulatory role for the trace element selenium?.  Exp and Clin Endocrinol. 1994;  102 63-89
• 13 Leonard J L, Rosenberg I N. Iodothyronine 5′-deiodinase from rat kidney: Substrate specificity and the 5′-deiodination of reverse triiodothyronine.  Endocrinology. 1980;  107 1376-1383
• 14 Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent.  J Biol Chem. 1951;  193 265-273
• 15 Moura E G, Rosenthal D, Carvalho-Guimaraes D P. Thyroid peroxidase activity in human nodular goiters.  Braz J Med and Biol Res. 1989;  22 31-39
• 16 Parma J, van Sande J, Tonacchera M, Dumont J, Vassart G. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of the hyperfunctioning thyroid adenomas: Identification of additional mutations activating both the cyclic adenosine 3′,5′-monophospate and inositol phosphate-Ca²⁺ cascades.  Mol Endocrinol. 1995;  9 725-733
• 17 Poertl S, Kirner J, Mann K, Hoermann R. Enhanced functional activity in thyroid adenomas in vitro.  Exp Clin Endocrinol Diabetes. 104 ((Suppl. 4)) 1996;  39-40
• 18 van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. Genetic basis of endocrine disease: Somatic and germline mutations of the TSH receptor gene in thyroid diseases.  J Clin Endocrinol Metab. 1995;  80 2577-2585
• 19 Schmutzler C, Winzer R, Jakobs T C, Meissner-Weigl, Simon D, Goretzki P E, Köhrle J. Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues.  Int J Cancer. 1998;  76 368-376
• 20 Studer H, Peter H J, Gerber H. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth.  Endocr Rev. 1989;  10 125-135
• 21 Stürch M, Peter H J, Gerber H, Studer H. Cold follicles in a multinodular human goiter arise partly from a failing iodide pump and partly from deficient iodine organification.  J Clin Endocrinol Metab. 1990;  71 1224-1229
• 22 Valenta L J. Thyroid peroxidase, thyroglobulin, cAMP and DNA in human thyroid.  J Clin Endocrinol Metab. 1976;  43 466-469